Avolta (AVOL) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
1 Nov, 2025Executive summary
Reported turnover for the first nine months of 2025 was CHF 10.609 billion, with CORE turnover at CHF 10.407 billion, up 5.8% at CER and 5.4% organically year-over-year.
CORE EBITDA margin expanded to 10.2%, a 30 basis point increase year-over-year, supported by cost and productivity improvements.
Achieved record equity free cash flow (EFCF) of CHF 503 million, up 13% year-over-year, with a conversion rate of 47.3%.
Leverage reduced to 1.9x net debt/CORE EBITDA, within the target range of 1.5x–2.0x.
October organic growth accelerated to 6.0% year-over-year, driven by positive momentum in North America.
Financial highlights
Turnover for nine months reached CHF 10.609 billion, with CORE turnover at CHF 10.407 billion; reported results impacted by FX headwinds.
EBITDA margin improved by 30 basis points to 10.2% for the nine months, and Q3 margin rose to 11.9%, up 37bps year-over-year.
EFCF for 9M 2025 was CHF 503 million, with Q3 EFCF at CHF 287 million (+23.7% YoY).
Leverage reduced to 1.9x net debt/CORE EBITDA from 2.2x in September 2024.
CHF 129 million spent on share buybacks (3.2 million shares) by end-September under a CHF 200 million program.
Outlook and guidance
Medium-term targets confirmed: organic growth of 5–7% per annum at CER, EBITDA margin expansion of 20–40bps, and EFCF conversion improvement of 100–150bps per annum.
October organic growth expected at +6.0% YoY, with North America showing an encouraging inflection.
Confident in meeting or exceeding full-year and multi-year targets due to geographic and segment diversification.
2025 currency translation expected to be -3% at current exchange rates.
Latest events from Avolta
- Strong growth, margin gains, and cash returns supported higher dividends and new buybacks.AVOL
Q4 202511 Mar 2026 - Robust 2024 growth, margin expansion, and higher shareholder returns; 2025 off to a strong start.AVOL
H2 202413 Feb 2026 - Turnover up 11%, EBITDA margin at 9%, and net profit to equity holders up 46.7%.AVOL
H1 20242 Feb 2026 - Record revenue, margin expansion, and share cancellation highlight robust growth and outlook.AVOL
Q3 2024 TU17 Jan 2026 - 5%-7% organic growth, margin gains, and higher shareholder returns targeted mid-term.AVOL
CMD 202520 Nov 2025 - Q1 2025 saw 8.2% turnover growth, margin expansion, and strong EMEA/LatAm performance.AVOL
Q1 2025 TU18 Nov 2025 - Organic growth 5.7%, EBITDA margin 9.3%, EPS up 28.7%, and leverage at 2.15x.AVOL
H1 202516 Nov 2025